Literature DB >> 20238072

Adeno-associated virus serotype-9 mediated retinal outer plexiform layer transduction is mainly through the photoreceptors.

Bo Lei1, Keqing Zhang, Yongping Yue, Arkasubhra Ghosh, Dongsheng Duan.   

Abstract

Due to its high ocular transduction, low immune clearance and capability to bypass the brain blood barrier, adeno-associated virus-9 (AAV9) has been regarded as a promising vector for retinal disease gene therapy. We recently demonstrated that AAV9 efficiently transduces the retinal outer plexiform layer (OPL). The OPL consists of synapses formed between axons of the rod and cone photoreceptors (cell bodies in the outer nuclear layer, ONL) and dendrites of bipolar and horizontal cells (cell bodies in the inner nuclear layer, INL). It is not clear whether AAV9 transduces the OPL through the photoreceptors in the ONL or through bipolar and horizontal cells in the INL. To map the subcelluar pathway(s) involved in AAV9-mediated OPL transduction, we delivered subretinally AAV9.CMV.eGFP, an AAV vector carrying the enhanced green fluorescent protein gene (eGFP, 1 x 10(10) viral genome particles in microliter), to young (21-day-old) and adult (2- to 3-month-old) C57BL/6 mice. Four weeks after subretinal injection, eGFP expression was examined on retinal cryosections. PSD95 (postsynaptic density protein, a marker for photoreceptor terminals), CtBP2 (C-terminal binding protein 2, a marker for the photoreceptor synaptic ribbon), PKCalpha (protein kinase Calpha, a marker for rod bipolar cells), and calbindin (a marker for horizontal cells) were localized by immunofluorescence staining. In AAV9 infected retina, eGFP expression was seen in the retinal pigment epithelia, photoreceptor inner segments, ONL, OPL, Müller cells in the INL, inner plexiform layer and ganglion cell layer. Interestingly, eGFP expression co-localized with PSD95 and CtBP2, but not with PKCalpha and calbindin. Our results suggest that AAV9 transduces the photoreceptor side of the synapses in the OPL rather than the dendrites of bipolar and horizontal cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20238072     DOI: 10.1007/978-1-4419-1399-9_77

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Mutation-independent rescue of a novel mouse model of Retinitis Pigmentosa.

Authors:  D L Greenwald; S M Cashman; R Kumar-Singh
Journal:  Gene Ther       Date:  2012-07-19       Impact factor: 5.250

2.  Degeneration of ipRGCs in Mouse Models of Huntington's Disease Disrupts Non-Image-Forming Behaviors Before Motor Impairment.

Authors:  Meng-Syuan Lin; Po-Yu Liao; Hui-Mei Chen; Ching-Pang Chang; Shih-Kuo Chen; Yijuang Chern
Journal:  J Neurosci       Date:  2018-12-26       Impact factor: 6.167

3.  Structural insight into the unique properties of adeno-associated virus serotype 9.

Authors:  Michael A DiMattia; Hyun-Joo Nam; Kim Van Vliet; Matthew Mitchell; Antonette Bennett; Brittney L Gurda; Robert McKenna; Norman H Olson; Robert S Sinkovits; Mark Potter; Barry J Byrne; George Aslanidi; Sergei Zolotukhin; Nicholas Muzyczka; Timothy S Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

4.  Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.

Authors:  Xiufeng Zhong; Hu Huang; Jikui Shen; Serena Zacchigna; Lorena Zentilin; Mauro Giacca; Stanley A Vinores
Journal:  Mol Vis       Date:  2011-02-17       Impact factor: 2.367

5.  Specific tools for targeting and expression in Müller glial cells.

Authors:  Lucie P Pellissier; Robert M Hoek; Rogier M Vos; Wendy M Aartsen; Ryan R Klimczak; Stefan A Hoyng; John G Flannery; Jan Wijnholds
Journal:  Mol Ther Methods Clin Dev       Date:  2014-03-19       Impact factor: 6.698

6.  Rescue of Defective Electroretinographic Responses in Dp71-Null Mice With AAV-Mediated Reexpression of Dp71.

Authors:  Mirella Telles Salgueiro Barboni; Cyrille Vaillend; Anneka Joachimsthaler; André Maurício Passos Liber; Hanen Khabou; Michel J Roux; Ophélie Vacca; Lucile Vignaud; Deniz Dalkara; Xavier Guillonneau; Dora Fix Ventura; Alvaro Rendon; Jan Kremers
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.